Latif A. Wafa

发表

Cyclin G‐associated kinase: A novel androgen receptor‐interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer

M. Gleave, L. Fazli, P. Rennie, 2006, International journal of cancer.

Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens

M. Gleave, L. Fazli, Shunyou Wang, 2006, The Prostate.

Androgen Receptor Coregulators and Their Role in Prostate Cancer

P. Rennie, R. Snoek, Latif A. Wafa, 2009 .

Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells

Paul S Rennie, Colleen C Nelson, P. Rennie, 2007, Molecular Cancer.

TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.

M. Gleave, A. Zoubeidi, L. Fazli, 2010, Molecular endocrinology.

Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.

M. Hirst, I. Sadowski, P. Rennie, 2003, The Biochemical journal.

In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors

M. Gleave, L. Fazli, P. Rennie, 2009, Clinical Cancer Research.

In vivo Knockdown of theAndrogen Receptor Results in Growth Inhibition and Regression of Well-Established , Castration-Resistant ProstateTumors

M. Gleave, L. Fazli, P. Rennie, 2008 .

Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors.

M. Gleave, L. Fazli, A. Hurtado-coll, 2007, Human pathology.

Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor‐axis in castration‐resistant prostate tumors

M. Gleave, L. Fazli, P. Rennie, 2012, The Prostate.

Carbidopa abrogates L‐dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression

M. Gleave, L. Fazli, P. Rennie, 2012, International journal of cancer.